News and Events

News

Vadim Gurvich is quoted in the Business Wire story, "NIPTE is Partner in Newly Announced National Biopharmaceutical Manufacturing 

bottles of pills

The U.S. Food and Drug Administration has awarded the National Institute for Pharmaceutical Technology and Education, Inc. (NIPTE) with up to $35M funding for a five-year period. The grant - a continuation of a multimillion-dollar FDA grant held by NIPTE since 2011 - supports scientific projects in various areas of pharmaceutical science and technology, such as improving manufacturing practices, quality of pharmaceutical products and the knowledge base of the scientific community.

image of pharmaceutical manufcaturing

The University of Minnesota will join a team of academic institutions, private companies, governmental entities and non-profit organizations across the U.S. as a partner for the newly established National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). NIIMBL, a public-private partnership supported by a $70M investment from the National Institute of Standards and Technology and at least $129M from other participants, aims to transform biopharmaceutical manufacturing in the U.S.

Gunda Georg

What does it take to get to that moment in a clinic when a doctor gives a patient a compound never before used in modern medicine? The story of Minnelide, an investigational drug for pancreatic cancer patients now in a Phase IA clinical trial at the University of Minnesota, illustrates just how complex and exhilarating that journey can be.

kava plant leaf

New research from the University of Minnesota College of Pharmacy and Masonic Cancer Center has found that consumption of the root of Piper methysticum, or kava, a plant native to the South Pacific Islands, may prevent the development of tobacco smoke-induced lung cancer.

courtney aldrich

Courtney Aldrich, associate professor of medicinal chemistry, has been named editor-in-chief of the American Chemical Society's new, web-only journal ACS Infectious Diseases. With the first issue slated for publication in January 2015, the pioneering journal will meet a growing demand for a place to publish top-notch chemistry-focused infectious diseases research.

National Institutes of Health logo

The University of Minnesota announced today it has been selected by the National Institutes of Health as one of three Research Evaluation and Commercialization Hub (REACH) sites nationally to establish a university-wide strategic framework promoting commercialization and technology transfer in the life sciences and biomedical technology.

Yusuf Abul-Hajj

Yusuf Abul-Hajj has been named an American Chemical Society (ACS) Fellow. He will be recognized at the society’s fall national meeting in Boston in August.

Dr. Abul-Hajj was recognized for his groundbreaking research in steroid carcinogenesis, identifying aromatase as playing a key role in breast cancer, detailing how Aromatase Inhibitors work on breast cancer, disseminating medicinal chemistry research as the Senior Editor of the Journal of Medicinal Chemistry, and as a symposium organizer at several ACS national meetings.

Pages